Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q48144731

about

An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Autonomic responses to exercise: group III/IV muscle afferents and fatigue.Muscular and functional effects of partitioning exercising muscle mass in patients with chronic obstructive pulmonary disease - a study protocol for a randomized controlled trial Submissive hypercapnia: Why COPD patients are more prone to CO2 retention than heart failure patients Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure.Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease.Effect of endurance versus resistance training on quadriceps muscle dysfunction in COPD: a pilot study Group III/IV locomotor muscle afferents alter motor cortical and corticospinal excitability and promote central fatigue during cycling exercise.Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD.Update in chronic obstructive pulmonary disease 2012.Are type III-IV muscle afferents required for a normal steady-state exercise hyperpnoea in humans?Muscle afferents and cardiorespiratory control: the Birmingham connection.Sensory nerves in lung and airways.Pathophysiology of human ventilatory control.Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.Perception of effort in Exercise Science: Definition, measurement and perspectives.The 'sensory tolerance limit': A hypothetical construct determining exercise performance?Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.Does impaired O2 delivery during exercise accentuate central and peripheral fatigue in patients with coexistent COPD-CHF?Muscle metabolism and activation heterogeneity by combined 31P chemical shift and T2 imaging, and pulmonary O2 uptake during incremental knee-extensor exercise.Critical Power: An Important Fatigue Threshold in Exercise Physiology.Muscle activation during exercise in severe acute hypoxia: role of absolute and relative intensity.Reply: To PMID 24142455.Do isolated leg exercises improve dyspnea during exercise in chronic obstructive pulmonary disease?Sinusoidal high-intensity exercise does not elicit ventilatory limitation in chronic obstructive pulmonary disease.Skeletal muscle power and fatigue at the tolerable limit of ramp-incremental exercise in COPD.No reserve in isokinetic cycling power at intolerance during ramp incremental exercise in endurance-trained men.Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease.Deception Improves TT Performance in Well-trained Cyclists without Augmented Fatigue.Group III/IV muscle afferents limit the intramuscular metabolic perturbation during whole body exercise in humans.Oxygen delivery and the restoration of the muscle energetic balance following exercise: implications for delayed muscle recovery in patients with COPD.The mechanism of the exercise hyperpnea: the ultrasecret revisited.Nonlinear exercise training in advanced chronic obstructive pulmonary disease is superior to traditional exercise training. A randomized trial.New perspectives concerning feedback influences on cardiorespiratory control during rhythmic exercise and on exercise performance.Heart Failure Impairs Muscle Blood Flow and Endurance Exercise Tolerance in COPD.Asymptomatic subjects with airway obstruction have significant impairment at exercise.Ventilatory responses to muscle metaboreflex activation in chronic obstructive pulmonary disease.Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD.Sympathetic Activation is Associated with Exercise Limitation in COPD.

P2860

Q33901722-69B9A3EC-1E7C-4A99-8937-5FF89B0C96D1 Q35108132-1A88C542-1FF7-46DE-8C9B-B69DC1E31E7C Q35580654-B15530FB-A0D3-4956-B423-E47B4E91BD41 Q36055031-40FF8229-DE62-4663-A366-0B66886BE252 Q36073977-E8D6E6F7-1149-4BFD-B623-9FDB8BD9E003 Q37346053-89C01806-AA70-4F84-AECF-6AC830F94CC3 Q37381482-6472FF95-F9D0-4868-AD9C-B177672769AD Q37589344-BECBA188-760C-46DF-AC89-172F0C3EB62E Q38083660-78D11F4E-0D7C-441B-9992-805CF92BD3B8 Q38118392-2D7AC1A8-60A0-4BEA-A168-C54A310CD600 Q38133779-91F21D20-2308-45D5-983E-BD678B3D8BCA Q38135401-6D4458E7-9EE2-4B05-A1C1-CE63612C14AA Q38201386-8A5D7D1B-431F-4ED0-B68D-B7863ED051A2 Q38219952-6A7AC8D7-8BE3-438F-9EC7-5D66E626B946 Q38243468-B68C7689-875D-4719-95AC-8F9479411945 Q38817813-D327462B-EBCF-4AFE-BBE2-0CD5D4A10636 Q38848089-4B03C088-CDAB-4D65-9224-B64325BF7470 Q39002056-5E6298D2-2DB7-4349-9255-DAA24E9B2F8F Q41338145-E94BE3A9-B1D8-4D37-9EF2-C63D25354758 Q42140872-823F19CA-0CD3-4753-A4A5-054E9741C557 Q42587363-9FBDA4CB-99AF-4508-AA35-32F5085002BE Q42709220-1F955318-2F69-4E5F-AAFD-2C5D19C38E2A Q43075142-2F25DD5F-F13F-4BB9-8C52-F22DE1891405 Q43098770-D5060E4F-5E89-408D-8DB5-1E4A3D6D93CA Q44705304-1A7C97BC-0519-49EB-BAFE-AFD04CB5CFCB Q45376603-A396FB5C-7E96-4DE9-AE37-99C823EE6FD0 Q45941316-1204E06A-2D2C-43C4-9C93-26C066CB2A34 Q46236479-AD68C84C-36E6-49FB-BBF1-3ACCCCF08D64 Q46410080-15C526B3-C96E-4EED-8F6E-D22B3595E570 Q46969446-F15DBD35-B949-413C-AC61-0FE06B9DC521 Q47425270-D468DAFE-F185-43F3-8519-31520A74F767 Q47945904-6E92F358-5523-4150-B012-867EAAEB8821 Q48126686-9E226853-01BF-49B4-842D-2DCB5601E360 Q48288814-D6526D0E-9972-486D-A9B0-97EBBA46AF3D Q48290241-BA8AFCDC-3A8C-4777-AA8B-7595F814FAAB Q50234803-4FD9F3B5-BD30-4DEA-927E-9FC304532D4E Q51517941-61CAFD4D-4E9B-4DDD-AE2D-732407379991 Q51525801-9D9659DA-7729-4927-BE11-C27C67073B19 Q51532447-0D130EC9-4A68-426F-A4F9-0AE121A4FB42 Q51540676-94ADF40D-1016-43A0-905E-0010DECBB919

P2860

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q48144731

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@en

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@nl

type

label

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@en

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@nl

prefLabel

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@en

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@nl

P1433

Q48144731-7A1C8EAF-B24B-4ADE-A5D3-AE8E627DCC98

P1476

Q48144731-AE475546-824F-4E9B-9728-6E93B998624E

P2093

Q48144731-28E588BE-D5B4-4BEB-BD87-37352B4D43B2

Q48144731-4121AC1A-5D12-4A54-BBDA-F72426FB9927

Q48144731-71A22980-36D9-4C1E-9CB0-78118F286716

Q48144731-87118B3B-7A18-4BBB-ABB6-CC2D68152058

Q48144731-C169A212-B2DA-4DCC-9E39-0041336E5C2D

Q48144731-CF705EBD-ED6C-4059-B267-4F05B4D1A7B1

Q48144731-D68E1470-873A-4BD6-BC42-A855D9DA0A3C

Q48144731-E660FEF2-0561-4244-8345-F6BFCB6D605A

P2860

Q48144731-085BBB0E-9DDA-4059-9582-5F5C9FD45A91

Q48144731-08BDB6E8-AB59-43C8-BE65-23B54939E419

Q48144731-0C243FF4-72B5-49F5-92CE-638A5581F488

Q48144731-1D812EBB-A859-402F-935B-DCADFC45FF11

Q48144731-1DB5BEA5-241C-4FE8-96A5-30D2B4973BB0

Q48144731-1F57B3F2-04A9-4FC8-B1B5-CC719A55E674

Q48144731-270AF794-21D8-4B52-9462-26D6DF9DE611

Q48144731-48766B2B-A5B6-4047-96BA-B2FAD1528018

Q48144731-4BB553AE-9BD7-47E0-AC3A-4A286E9F115D

Q48144731-65933FE6-A512-40E1-BC43-41FA71F3FED0

P304

Q48144731-73576AAE-9538-4F0C-9C3C-4DBEDE301B65

P31

Q48144731-9B481ABE-95B9-46C6-96BC-969393213EDF

P356

Q48144731-48C4FA15-2063-408A-A404-B6728EC03143

P407

Q48144731-29324F95-A2B9-4400-B206-D3E127F6F93E

P433

Q48144731-81EEB29D-0E9C-4596-BC07-25CFFF5F9F59

P478

Q48144731-9272EE5D-E180-4AB0-BF09-2329F21D6C40

P577

Q48144731-6758C11B-AC7D-4074-94F5-15760DF78597

P698

Q48144731-AE1F8B26-4A2E-4630-9100-D06ED21E1E39

P921

Q48144731-5B44EC1A-CBCF-46A5-A8BB-DB1E360C84C6

Q48144731-7908326A-B003-4249-B18A-3A1D93C6E9F5

P356

RCCM.201203-0404OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Influences of spinal anesthesi ...... obstructive pulmonary disease.

@en

P2093

Didier Saey

http://www.w3.org/2001/XMLSchema#string

Fernanda Ribeiro

http://www.w3.org/2001/XMLSchema#string

François Maltais

http://www.w3.org/2001/XMLSchema#string

Jean S Bussières

http://www.w3.org/2001/XMLSchema#string

Nathalie Gagné

http://www.w3.org/2001/XMLSchema#string

Philippe Gagnon

http://www.w3.org/2001/XMLSchema#string

Serge L Gagnon

http://www.w3.org/2001/XMLSchema#string

Steeve Provencher

http://www.w3.org/2001/XMLSchema#string

P2860

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans.

Ventilatory limitations in chronic obstructive pulmonary disease.

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

Influence of sympathetic stimulation and vasoactive substances on the canine pulmonary veins.

Afferent pain pathways: a neuroanatomical review.

Muscle afferent contributions to the cardiovascular response to isometric exercise.

Respiratory control at exercise onset: an integrated systems perspective.

Side effects of intrathecal and epidural opioids.

P304

606-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201203-0404OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22822019

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease